This topic contains a solution. Click here to go to the answer

Author Question: Which is a major criticism of Kubler-Ross's stages of dying? a. It lacks universality. b. It ... (Read 114 times)

anshika

  • Hero Member
  • *****
  • Posts: 510
Which is a major criticism of Kubler-Ross's stages of dying?
 
  a. It lacks universality.
  b. It needs to be expanded to include other behaviors.
  c. It does not take into consideration infant deaths.
  d. It is too biologically oriented.
  e. It does not take into consideration the death of the elderly.

Question 2

The process whereby an individual withdraws from society or society withdraws from or no longer seeks the individual's efforts is known as
 
  a. withdrawal syndrome.
  b. phase-out behavior.
  c. activity theory.
  d. disengagement.
  e. depression response.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Dinolord

  • Sr. Member
  • ****
  • Posts: 313
Answer to Question 1

A

Answer to Question 2

D




anshika

  • Member
  • Posts: 510
Reply 2 on: Jun 22, 2018
YES! Correct, THANKS for helping me on my review


mohan

  • Member
  • Posts: 362
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Giardia is one of the most common intestinal parasites worldwide, and infects up to 20% of the world population, mostly in poorer countries with inadequate sanitation. Infections are most common in children, though chronic Giardia is more common in adults.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

For a complete list of videos, visit our video library